Ixekizumab May Improve Renal Function in Psoriasis.

Giuseppe Fabrizio AmorusoSteven Paul NisticòLuigi IannoneEmilio RussoGiuseppe RagoCataldo Patruno Luigi Bennaro

Published in: Healthcare (Basel, Switzerland) (2021)

IL17A blockage may help to treat various autoimmune and inflammatory conditions, such as psoriasis, that may lead to renal impairment. Further investigation is necessary in order to prove the effectiveness of this drug in renal conditions.

Keyphrases

randomized controlled trial
systematic review
multiple sclerosis
oxidative stress
drug induced
emergency department
hidradenitis suppurativa